Viewing Study NCT01362660


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-05-18 @ 8:59 AM
Study NCT ID: NCT01362660
Status: COMPLETED
Last Update Posted: 2013-02-06
First Post: 2011-05-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Infants With Potential Exposure to Tanezumab Before Birth
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Infant Developmental Assessment View
Keywords:

Keywords

Keyword Brief Keyword Text View
None post-natal monitoring View
None exposure in utero View